Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The few studies that exist are very small, low-quality, or were only tested on animals and cellsnot humans
AOD-9604 Peptide Regulatory Status in Canada Health Canada Regulatory Status - Unapproved Investigational Compound AOD-9604 has never been authorized by Health Canada or any other major health authority worldwide for any human or veterinary indication
Treatment day: A licensed provider cleans the skin and performs a quick intramuscular injection, usually in the upper arm or hip
For inflammatory bowel disease models, BPC-157 reduced macroscopic and histologic damage scores in TNBS-induced colitis in rats, with effects observed within 7 days of treatment 6
Revisado mdicamente por el Equipo Mdico de FormBlends Mdicos licenciados e investigadores clnicos con experiencia en terapias de pptidos ltima actualizacin Marzo 2026 Respuesta Rpida: Las dosificaciones de BPC-157 en investigacin tpicamente oscilan de 200 a 800 mcg por da, administradas una o dos veces al da va inyeccin subcutnea o cpsula oral
These simple, short-term limits help healing and reduce the chance of prolonged discomfort
US$ 21.56
US$ 24.68
US$ 25.81
US$ 21.56
US$ 29.42
US$ 20.12
